This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Akira Inomata: Innovator in Pharmaceutical Chemistry
Introduction
Akira Inomata is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with pharmacological applications. With a total of 2 patents, Inomata's work is recognized for its potential impact on drug development.
Latest Patents
Inomata's latest patents include a Pyrazolothiazole compound, which is represented by a specific formula. This compound exhibits excellent CRF receptor antagonism, making it a promising candidate for pharmacological applications. The compound's structure allows for various substitutions, enhancing its potential efficacy and safety as a drug.
Career Highlights
Inomata is currently associated with Eisai R&D Management Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on creating compounds that demonstrate significant pharmacological activity and favorable pharmacokinetic properties.
Collaborations
Inomata collaborates with talented individuals in his field, including Kogyoku Shin and Taro Terauchi. Their combined expertise contributes to the advancement of research and development in pharmaceutical chemistry.
Conclusion
Akira Inomata's contributions to the field of pharmaceutical chemistry through his innovative patents highlight his role as a key inventor. His work continues to pave the way for advancements in drug development and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile